Canada announces major contribution for Stop TB Partnership's TB REACH Initiative

A 5-year award of CA$85 million will support innovations in TB detection and care through Stop TB Partnership's TB REACH initiative.

Read More →

Tackling drug-resistant infections globally: final report and recommendations

The Review on Antimicrobial Resistance released its final report and recommendations warning that antimicrobial-resistant infections such as drug-resistant tuberculosis could kill 10 million people a year by 2050 without an urgent expansion of resources and funds.

Read More →

Rapid Clinical Advice on new TB drugs in children

The Sentinel Project’s Advocacy Task Force has developed Rapid Clinical Advice on the use of new TB drugs bedaquiline and delamanid in children.

Read More →

Stop TB Partnership launches seven key population briefs

The Stop TB Partnership released a series of briefs on TB key populations recognizing that reaching everyone with services, diagnostics, treatment and care is essential to ending the TB epidemic. The briefs focus on children, miners, mobile populations, urban populations, prisoners, rural populations and people who use drugs.

Read More →

Silicosis: miners win case for class certification

The South Gauteng High Court in Johannesburg has certified the first class action in South African history for sick workers, allowing gold miners suffering from silicosis and tuberculosis to proceed with their claims against 30 gold producers. Obstacles remain before sick miners receive compensation but this is an important victory for them.

Read More →

World Health Organization recommends shorter treatment for multidrug-resistant TB

New World Health Organization recommendations aim to speed up detection and improve treatment outcomes for multidrug-resistant TB through use of a novel rapid diagnostic test and a shorter, cheaper treatment regimen.

Read More →

Position paper: Sustainable transition from donor support in Eastern Europe and Central Asia

TB Europe Coalition released a position paper with recommendations for stakeholders in countries in Eastern Europe and Central Asia (EECA) to ensure a sustainable and responsible transition from donor support, and continued scale up of TB and HIV activities.

Read More →

Stop TB Partnership Global Drug Facility announces 70 percent price reduction for linezolid

Linezolid is a critical component of regimens used to treat multidrug-resistant tuberculosis (MDR-TB). The GDF-negotiated price reduction is projected to save up to US$ 30 million over the next three years, helping to further improve equitable access to MDR-TB treatment.

Read More →

Lives on the Edge: Time to align medical research and development with people’s health needs

Médecins Sans Frontières (MSF) released a report that outlines shortcomings of the current system for new drug development. The report highlights resulting access barriers and proposes policy solutions.

Read More →

Advocates, alarmed by appalling global response to MDR-TB outbreak in Papua New Guinea, call on international agencies to take action

Advocates denounced the global response to an MDR-TB outbreak in Papua New Guinea and urged international agencies to immediately intervene.

Read More →

Page 1 of 69 · Total posts: 10

1 2 Last→